Oxford Launches UK Trial of Rapidly Developed Ebola Vaccine as Outbreak Response Accelerates
Oxford begins a UK trial of a rapidly developed Ebola vaccine targeting the Bundibugyo strain amid an ongoing outbreak.
Research on bacteria, viruses, fungi and the microbiome, and how they affect human health.
Nature Spotlights the Science Behind Peptide Injections as Wellness Demand Rises
Nature examines the peptide injection boom and warns that wellness hype is outpacing scientific evidence.
Sepsis AI Tool Wins FDA Clearance as Hospitals Seek Earlier Infection Warnings
Johns Hopkins’ AI sepsis warning system wins FDA clearance, highlighting the growing role of AI in early hospital infection detection.
Gut Microbes Could Offer an Early Warning for Parkinson’s Risk
UK researchers say gut microbes could help flag Parkinson’s risk before symptoms appear, opening the door to earlier intervention.
International Study: The Gut Microbiome Linked to Slower Cognitive Decline in Older Adults
Studiu internațional pe 4.500+ pacienți arată o asociere între anumite profiluri ale microbiomului intestinal și încetinirea declinului cognitiv la vârstnici; rezultatele îndeamnă la trialuri clinice adiacente.
